Design of an Enhanced Public Health Surveillance System for Hepatitis C Virus Elimination in King County, Washington.


Journal

Public health reports (Washington, D.C. : 1974)
ISSN: 1468-2877
Titre abrégé: Public Health Rep
Pays: United States
ID NLM: 9716844

Informations de publication

Date de publication:
01 2020
Historique:
entrez: 14 12 2019
pubmed: 14 12 2019
medline: 21 4 2020
Statut: ppublish

Résumé

With the goal of eliminating hepatitis C virus (HCV) as a public health problem in Washington State, Public Health-Seattle & King County (PHSKC) designed a Hepatitis C Virus Test and Cure (HCV-TAC) data system to integrate surveillance, clinical, and laboratory data into a comprehensive database. The intent of the system was to promote identification, treatment, and cure of HCV-infected persons (ie, HCV care cascade) using a population health approach. The data system automatically integrated case reports received via telephone and fax from health care providers and laboratories, hepatitis test results reported via electronic laboratory reporting, and data on laboratory and clinic visits reported by 6 regional health care systems. PHSKC examined patient-level laboratory test results and established HCV case classification using Council of State and Territorial Epidemiologists criteria, classifying patients as confirmed if they had detectable HCV RNA. The data enabled PHSKC to report the number of patients at various stages along the HCV care cascade. Of 7747 HCV RNA-positive patients seen by a partner site, 5377 (69%) were assessed for severity of liver fibrosis, 3932 (51%) were treated, and 2592 (33%) were cured. Data supported local public heath surveillance and HCV program activities. The data system could serve as a foundation for monitoring future HCV prevention and control programs.

Identifiants

pubmed: 31835010
doi: 10.1177/0033354919889981
pmc: PMC7119250
doi:

Substances chimiques

Antiviral Agents 0
RNA, Viral 0

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-39

Références

Clin Infect Dis. 2014 Sep 15;59(6):755-64
pubmed: 24917659
Ann Intern Med. 2013 Sep 3;159(5):349-57
pubmed: 23798026
Hepatology. 2019 Mar;69(3):1020-1031
pubmed: 30398671
Open Forum Infect Dis. 2018 Jul 03;5(7):ofy153
pubmed: 30046641
MMWR Recomm Rep. 2012 Aug 17;61(RR-4):1-32
pubmed: 22895429
Am J Epidemiol. 2019 Mar 1;188(3):555-561
pubmed: 30535062
J Telemed Telecare. 2012 Dec;18(8):481-4
pubmed: 23209269

Auteurs

Atar Baer (A)

Public Health-Seattle & King County, Seattle, WA, USA.

Meaghan S Fagalde (MS)

Public Health-Seattle & King County, Seattle, WA, USA.

Curtis D Drake (CD)

Public Health-Seattle & King County, Seattle, WA, USA.

Elisabeth H Sohlberg (EH)

Public Health-Seattle & King County, Seattle, WA, USA.

Elizabeth Barash (E)

Public Health-Seattle & King County, Seattle, WA, USA.

Sara Glick (S)

Division of Allergy and Infectious Diseases, School of Medicine, University of Washington, Seattle, WA, USA.

Alexander J Millman (AJ)

Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Jeffrey S Duchin (JS)

Public Health-Seattle & King County, Seattle, WA, USA.
Division of Allergy and Infectious Diseases, School of Medicine, University of Washington, Seattle, WA, USA.
School of Public Health, University of Washington, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH